NCT05162391View on ClinicalTrials.gov

Inflammation in Methamphetamine and STIs (IMSTI)

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Methamphetamine-dependenceRectal GonorrheaRectal Chlamydia
Interventions
BEHAVIORAL

Contingency Management

Contingency management intervention with incentives tied to provision of urine samples with no detectable levels of methamphetamine (MA).

Trial Locations (1)

90038

UCLA Vine Street Clinic, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER